Comparer des méthodes

	Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)	Échelle de qualité de vie spécifique à l'AVC (SS-QoL)
Domaine	Neurologie	Neurologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2001	1999
Auteur d'origine	Mark I. Bennett, University of Leeds	Lee S. Williams, Indiana University
Type	Hybrid questionnaire and clinician examination	Self-report questionnaire
Source fondatrice	Bennett, M. I. (2001). The LANSS Pain Scale: The Leeds Assessment of Neuropathic Symptoms and Signs. Pain, 92(1-2), 147-157.	Williams, L. S., Weinberger, M., Harris, L. E., Clark, D. O., & Biller, J. (1999). Development of a Stroke-Specific Quality of Life Scale. Stroke, 30(7), 1362-1369.
Alias	LANSS Pain Scale, Leeds Neuropathic Symptoms	Stroke-Specific QoL, SS-QOL
Apparentées	4	4
Résumé	The LANSS is a brief seven-item hybrid screening and diagnostic tool designed to differentiate neuropathic pain from non-neuropathic (nociceptive) pain. Developed by Mark Bennett at the University of Leeds in 2001, it combines five patient-reported symptom items with two clinician-performed neurological examination findings. With a sensitivity of 82% and specificity of 80%, LANSS is among the most accurate tools for identifying whether a patient's pain has a neuropathic component, making it invaluable in clinical practice and research settings where pain etiology classification is essential.	The SS-QoL is a disease-specific quality-of-life instrument designed to capture the multidimensional impact of stroke on survivors' functional and emotional well-being. Developed by Williams and colleagues in 1999, this 49-item scale addresses stroke-specific concerns including language, cognition, mobility, and emotional functioning. It is a gold-standard instrument for stroke outcome research and routine clinical monitoring of post-stroke recovery.